QT
TMCI icon

Quantbot Technologies’s Treace Medical Concepts TMCI Stock Holding History

Quantbot Technologies’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,497
Closed -$115K – 2109
2025
Q2 		$115K Sell
19,497
-9,339
-32% -$60.8K ﹤0.01% 1374
2025
Q1 		$242K Buy
28,836
+19,500
+209% +$175K 0.01% 1086
2024
Q4 		$69.5K Buy
+9,336
New +$62.5K ﹤0.01% 1276
2023
Q2 		– Sell
-22,883
Closed -$576K – 1958
2023
Q1 		$576K Buy
22,883
+6,524
+40% +$153K 0.04% 570
2022
Q4 		$376K Sell
16,359
-2,574
-14% -$59.3K 0.03% 680
2022
Q3 		$417K Buy
+18,933
New +$366K 0.03% 636

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantbot Technologies's TMCI Position: Q3 2025 in Review

Quantbot Technologies sold out of Treace Medical Concepts (TMCI) in Q3 2025, closing a stake of 19,497 shares — an estimated $115K sold.

Quantbot Technologies first reported a position in TMCI in Q3 2022 and held it in 6 quarters. The position peaked at $576K in Q1 2023. 119 funds tracked by Wall St. Rank hold TMCI as of Q3 2025.

  • Quantbot Technologies reported no remaining Treace Medical Concepts position as of Q3 2025 after selling out during the quarter.
  • Quantbot Technologies sold 19,497 Treace Medical Concepts shares in Q3 2025, an estimated $115K.
  • Quantbot Technologies first reported a position in Treace Medical Concepts in Q3 2022 and held it in 6 quarters.
  • Quantbot Technologies's Treace Medical Concepts position peaked at $576K in Q1 2023.
  • 119 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2025.

Based on Quantbot Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.